STAGE IVA LIVER CANCER
Clinical trials for STAGE IVA LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LIVER CANCER trials appear
Sign up with your email to follow new studies for STAGE IVA LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The drug is designed to make tumor cells more sensitive to radiation therapy. Researchers aim to find the safest dose and see how well the…
Matched conditions: STAGE IVA LIVER CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 01, 2026 16:01 UTC
-
One-Day liver cancer treatment could cut hospital time and costs
Symptom relief OngoingThis early-stage trial tests whether a liver cancer treatment called Y90 radioembolization can be safely done in a single session instead of the usual two days. The study involves 12 patients with liver cancer that has spread. The goal is to see if this faster approach reduces tr…
Matched conditions: STAGE IVA LIVER CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 16:01 UTC